Brian Bolan, the aggressive growth stock strategist at Zacks Investment Research has two cyber security names for your review. The first is Qualys (QLYS - Free Report) and it sports a Zacks Rank #1 (Strong Buy) and an excellent divergence. The divergence that Brian often speaks about is the difference in the growth and value scores, which he prefers to be polar opposites. QLYS has a great history of beating the number and also has a wonderful chart. The next stock is in the same space and has the divergence that we talk a lot about. Imperva is also a Zacks Rank #1 (Buy) and the chart shows some great moves in earnings estimate revisions.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Brian Bolan, the aggressive growth stock strategist at Zacks Investment Research has two cyber security names for your review. The first is Qualys (QLYS - Free Report) and it sports a Zacks Rank #1 (Strong Buy) and an excellent divergence. The divergence that Brian often speaks about is the difference in the growth and value scores, which he prefers to be polar opposites. QLYS has a great history of beating the number and also has a wonderful chart. The next stock is in the same space and has the divergence that we talk a lot about. Imperva is also a Zacks Rank #1 (Buy) and the chart shows some great moves in earnings estimate revisions.
The Hottest Tech Mega-Trend of All
Last year, it generated $8 billion in global revenues. By 2020, it's predicted to blast through the roof to $47 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.
See Zacks' 3 Best Stocks to Play This Trend >>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on QLYS - FREE